CompletedNCT00324116
Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions
PHASE4 · 81 planned enrolment
- Countries listed
- 1
- Registry update
- March 23, 2010
Registry Intervention View
pegaptanib sodium (Macugen)
Trial registrations containing the exact intervention label pegaptanib sodium (Macugen).
Exact registry label · Not reported
3 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
1 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
UnknownNCT00354445
A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD
PHASE4 · 1,000 planned enrolment
- Countries listed
- 1
- Registry update
- January 15, 2007
CompletedNCT00215670
Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)
PHASE2 · PHASE3 · 125 planned enrolment
- Countries listed
- 0
- Registry update
- May 3, 2006